Consensus
The community is moderately leaning bullish on Novo Nordisk at 65%, based on 6 forecasts. Forecasters are in moderate agreement.
Resolves YES if Novo Nordisk's price 180 days out is above its baseline price.
Share your read on this question — the best forecasters show their work.
See the whole nvo discussion →